Fangying Lu
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 4
-
- Vitamin D Research Studies 2
- Co-authors
- Min Zhou (4 shared papers)Weining Xiong (3 shared papers)Dexiang Yang (3 shared papers)Xin Li (1 shared paper)Yong Li (1 shared paper)Hanssa Summah (2 shared papers)Jian Li (2 shared papers)Yun Ling (2 shared papers)
In The Last Decade
Fangying Lu
15 papers receiving 743 citations
Fangying Lu's Hit Papers
Peers
Comparison fields: 5 of 80
- Infectious Diseases 404
- Applied Microbiology and Biotechnology 27
- Neurology 181
- Critical Care and Intensive Care Medicine 27
- Pathology and Forensic Medicine 57
Countries citing papers authored by Fangying Lu
This map shows the geographic impact of Fangying Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangying Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangying Lu more than expected).
Fields of papers citing papers by Fangying Lu
This network shows the impact of papers produced by Fangying Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangying Lu. The network helps show where Fangying Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fangying Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | COVID-19 with Different Severities: A Multicenter Study of Clinical Features Hit paper breakdown → | 2020 | 602 |
| 2 | 2014 | 55 | |
| 3 | 2021 | 27 | |
| 4 | 2022 | 19 | |
| 5 | 2022 | 10 | |
| 6 | 2020 | 8 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 6 | |
| 9 | 2021 | 5 | |
| 10 | 2023 | 4 | |
| 11 | 2020 | 4 | |
| 12 | 2024 | 4 | |
| 13 | 2023 | 3 | |
| 14 | 2024 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2026 | 0 | |
| 17 | 2022 | 0 | |
| 18 | 2024 | 0 | |
| 19 | 2023 | 0 |
About Fangying Lu
Fangying Lu is a scholar working on Infectious Diseases, Pathology and Forensic Medicine, Surgery, Molecular Biology and Neurology, having authored 19 papers that have together received 757 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Vitamin D Research Studies (2 papers), Nutrition and Health in Aging (2 papers), Body Composition Measurement Techniques (1 paper), Chronic Obstructive Pulmonary Disease (COPD) Research (1 paper), Osteoarthritis Treatment and Mechanisms (1 paper), Muscle Physiology and Disorders (1 paper) and Bone Metabolism and Diseases (1 paper). The work is most often cited by research in Infectious Diseases (404 citations), Applied Microbiology and Biotechnology (27 citations), Neurology (181 citations), Critical Care and Intensive Care Medicine (27 citations) and Pathology and Forensic Medicine (57 citations). Fangying Lu has collaborated with scholars based in China and Kuwait. Frequent co-authors include Min Zhou, Weining Xiong, Dexiang Yang, Xin Li, Yong Li, Hanssa Summah, Jian Li, Yun Ling, Xuhui Liu and Yuqing Chen. Their work appears in journals such as Aging Clinical and Experimental Research, Frontiers in Pharmacology, Diabetic Medicine, International Journal of COPD and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.